Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of fina…
Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of fina…
Hyperliquid has traded within a descending channel since it faced rejection at $72 three weeks ago. Over this …
It is less than two days until MemeCore’s [M] next unlock, and the market appears to be reacting early. The to…
Astarter, a Web4 Artificial Intelligence (AI) infrastructure platform, is excited to announce its groundbreaki…
Uniswap, the leading decentralized exchange protocol, has introduced a new feature called Earn, now available …
Self-custody wallet provider Ready and Solana-based wallet Solflare have suspended their crypto card services …
$XRP price briefly climbed to $1.10 before easing back as steady ETF inflows and Aviva Investors' tokenized fu…
Uniswap ($UNI) price has reclaimed the $4 level after climbing more than 9% in the past 24 hours, extending it…
Demystifying RWA Tokenization and Illiquidity Commercial maritime shipping has for centuries remained one of g…
$NEAR AI, a platform for confidential AI computing and autonomous agents, has launched a new way to pay for AI…
Users of MOACT, the rewards app run by a wholly owned subsidiary of Japanese utility Kansai Electric Power, ca…
Avalanche [$AVAX] is secretly preparing the groundwork. This could lead to the potential launch of a powerful …